Jason Mraz is the President and co-founding partner of Ospraie Management and has been involved in business development, fund creation and co-portfolio management, leading trading and private investments over the span of his tenure at Ospraie. He currently focuses on the development and platform of the Ospraie Ag Science team which invests in catalytic agriculture biotechnology. Mr. Mraz is also the President and co-founder of Concarlo Therapeutics, a biotech company focused on transformative solutions for drug-resistant cancers, where he leads all investment and financial matters. He began his career at JPMorgan, trading foreign bonds, currencies, and long bonds on the US Treasury desk. He